Austria · Delayed Price · Currency is EUR Biogena Good Vibes AG Statistics
Total Valuation
VIE:BIOG has a market cap or net worth of EUR 559.78 million. The enterprise value is 722.50 million.
| Market Cap | 559.78M |
| Enterprise Value | 722.50M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
VIE:BIOG has 97.35 million shares outstanding.
| Current Share Class | 97.35M |
| Shares Outstanding | 97.35M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 90.87% |
| Owned by Institutions (%) | n/a |
| Float | 8.89M |
Valuation Ratios
The trailing PE ratio is 0.54.
| PE Ratio | 0.54 |
| Forward PE | n/a |
| PS Ratio | 4.48 |
| PB Ratio | 6.53 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 45.07 |
| P/OCF Ratio | 22.36 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 38.59, with an EV/FCF ratio of 58.17.
| EV / Earnings | 466.71 |
| EV / Sales | 5.78 |
| EV / EBITDA | 38.59 |
| EV / EBIT | 87.59 |
| EV / FCF | 58.17 |
Financial Position
The company has a current ratio of 0.63, with a Debt / Equity ratio of 1.99.
| Current Ratio | 0.63 |
| Quick Ratio | 0.34 |
| Debt / Equity | 1.99 |
| Debt / EBITDA | 9.11 |
| Debt / FCF | 13.73 |
| Interest Coverage | 1.14 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 3.35% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 306,147 |
| Profits Per Employee | 3,794 |
| Employee Count | 408 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -298,102 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 8,637 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, VIE:BIOG had revenue of EUR 124.91 million and earned 1.55 million in profits. Earnings per share was 10.59.
| Revenue | 124.91M |
| Gross Profit | 95.38M |
| Operating Income | 8.25M |
| Pretax Income | 1.32M |
| Net Income | 1.55M |
| EBITDA | 13.35M |
| EBIT | 8.25M |
| Earnings Per Share (EPS) | 10.59 |
Balance Sheet
The company has 9.74 million in cash and 170.51 million in debt, with a net cash position of -160.78 million or -1.65 per share.
| Cash & Cash Equivalents | 9.74M |
| Total Debt | 170.51M |
| Net Cash | -160.78M |
| Net Cash Per Share | -1.65 |
| Equity (Book Value) | 85.70M |
| Book Value Per Share | 540.90 |
| Working Capital | -19.76M |
Cash Flow
In the last 12 months, operating cash flow was 25.03 million and capital expenditures -12.61 million, giving a free cash flow of 12.42 million.
| Operating Cash Flow | 25.03M |
| Capital Expenditures | -12.61M |
| Depreciation & Amortization | 5.10M |
| Net Borrowing | 11.81M |
| Free Cash Flow | 12.42M |
| FCF Per Share | 0.13 |
Margins
Gross margin is 76.36%, with operating and profit margins of 6.60% and 1.24%.
| Gross Margin | 76.36% |
| Operating Margin | 6.60% |
| Pretax Margin | 1.06% |
| Profit Margin | 1.24% |
| EBITDA Margin | 10.69% |
| EBIT Margin | 6.60% |
| FCF Margin | 9.94% |
Dividends & Yields
VIE:BIOG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 172.60% |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.28% |
| FCF Yield | 2.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VIE:BIOG has an Altman Z-Score of 0.34 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.34 |
| Piotroski F-Score | 3 |